Cold Light Projector TECHNOLIGHT 270

...er is the first instrument engineered to match the...rapid temperature cycling system is based on heat ...apillary tubes or thin walled micorcentrifuge tube...high velocity air results in nearly instantaneous ...

...e Tetrad™ thermal cycler expands the envelop...ngine™ cyler. It has four times the capacity...ery high throughput for laboratories that run mass... diagnostic labs. Four blocks, each available wit...

Excellent performance, small footprint, simple intuitive programming and almost completely noiseless operation make the Primus 25 the ideal personal cycler in the modern laboratory workplace. , ,

...stems has designed its 60-well, 0.5 mL GeneAmp PCR...CR applications (both DNA and RNA). The heated lid... oil-free operation in the 0.5 mL format.,Des...5 mL GeneAmp PCR System 9700 can easily be expande...

(Date:1/8/2009)...ution Key Factor in Decision for Florida Multi-Spe...n. 8 Allscripts announce...largest multi-specialty group practices in the Sou...Enterprise(TM) Electronic Health Record (EHR) to a...ces across Central Florida. , , (Logo: http:...

(Date:1/8/2009)...dents will dance to raise money for Camp Courage a...wswire/ -- , , , WHO: Dance students...alent in the 3rd annual Dance, wit.... The, event will be emceed by To... Participants raise money through pledges to be...

(Date:1/8/2009)...PRNewswire-FirstCall/ -- Medivation, Inc.,(Nasdaq...president and chief,executive officer, will prese...erence on Wednesday, January 14, at 10:00 a.m. Pac...Francisco. , Dr. Hung will provide an overv...ograms for Dimebon for Alzheimer,s and Huntington,...

(Date:1/8/2009)...ing traditional risk factors, experts say , ...ecular signs -- or "biomarkers" -- of inflammation...ess a person,s risk of stroke, new research says. ...g these markers does not change things much," said... at the Methodist DeBakey Heart & Vascular Cen...

...ail, that siRNA packed as a tiny sphere can shrink...y of Texas M. D. Anderson Cancer Centre had report...esearch, that siRNA that are wrapped up in a tiny ...cancer tumour cells, which could thereby oppress t...

...f The New England Journal of Medicine, UCLA resear...coccus aureus (MRSA) to be// the most common cause...across the nation. Many patients presenting to th...ions were found to be having MRSA infection that w...

...f the journal Neuron, published by Cell Press, res...e Araujo and colleagues,// have mapped the activit...tiety-hunger cycle in multiple feeding-related bra...involved in the hunger/satiety cycle have been onl...

...f-immolation has decided to approach the National ... to the government’s failure// to provide any help...ing against non-payment of bills due to him by the...s 30s, sustained about 80 percent burns after sett...

(Date:1/8/2009)...stern to Identify and Validate Novel Gene Expressi...ative Gene Expression Platform , , FREMONT, Cal...systems, Inc. (OTC Bulletin Board: WGBS), a leadin...enotyping, cell biology and stem cell research sys...llaboration with the University of Texas Southwes...

(Date:1/7/2009)...APOLIS, Jan. 7 Eli Lilly...it received a complete response letter from,the U...ine long-acting,injection (LAI) for acute and mai...lly is continuing to work with the agency on the n...not require any additional clinical trials for the...

(Date:1/7/2009)...everal Products in Development Based On Osteotech,...te Natural BioRegeneration; FDA Filing Anticipated...n. 7 Osteotech, Inc. (...f biologic products for regenerative healing, anno...al trial for its DuraTech(TM) BioRegeneration Matr...

(Date:1/6/2009)...nificance of AHCC for maintaining a healthy immune... -- A recently published study in Nutrition and C...edical University in Osaka, Japan has shown that A...mmune function by increasing the number of dendrit...ystem responsible for presenting foreign substance...

...n--(BUSINESS WIRE)--May 1, 2007 - Teva,Pharmaceuti...nounced that data from a 36-week, randomized, doub...strated that an oral 0.6 mg,dose of laquinimod giv...imaging (MRI) disease activity by 38 percent in RR...here was a favorable,trend towards reducing annual...

...d Signs of Disease Activity as Measured,by MRI and...Genentech, Inc.,(NYSE: DNA) and Biogen Idec, Inc. ... Phase II clinical study of Rituxan®,(rituxima...clerosis,(RRMS) were presented today at the Americ...ton. Rituxan is a therapeutic antibody,that target...